Mirum Pharmaceuticals, Inc. 08D.F Stock
Mirum Pharmaceuticals, Inc. Price Chart
Mirum Pharmaceuticals, Inc. 08D.F Financial and Trading Overview
| Mirum Pharmaceuticals, Inc. stock price | 23 EUR |
| Previous Close | 25.8 EUR |
| Open | 25.8 EUR |
| Bid | 25.4 EUR x N/A |
| Ask | 26.4 EUR x N/A |
| Day's Range | 25.8 - 25.8 EUR |
| 52 Week Range | 16.3 - 27.6 EUR |
| Volume | 30 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 981.22M EUR |
| Beta (5Y Monthly) | 1.321165 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.44 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.29 EUR |
08D.F Valuation Measures
| Enterprise Value | 851.12M EUR |
| Trailing P/E | N/A |
| Forward P/E | -7.747748 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.245807 |
| Price/Book (mrq) | 6.948559 |
| Enterprise Value/Revenue | 8.887 |
| Enterprise Value/EBITDA | -7.011 |
Trading Information
Mirum Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 1.321165 |
| 52-Week Change | 39.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.6 EUR |
| 52 Week Low | 16.3 EUR |
| 50-Day Moving Average | 23.68 EUR |
| 200-Day Moving Average | 21.47 EUR |
08D.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 38.03M |
| Float | 28.07M |
| Short Ratio | N/A |
| % Held by Insiders | 3.77% |
| % Held by Institutions | 91.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -134.89% |
| Operating Margin (ttm) | -131.18% |
| Gross Margin | 84.41% |
| EBITDA Margin | -126.76% |
Management Effectiveness
| Return on Assets (ttm) | -25.67% |
| Return on Equity (ttm) | -103.31% |
Income Statement
| Revenue (ttm) | 95.77M EUR |
| Revenue Per Share (ttm) | 2.7 EUR |
| Quarterly Revenue Growth (yoy) | 145.09% |
| Gross Profit (ttm) | 64.69M EUR |
| EBITDA | -121399000 EUR |
| Net Income Avi to Common (ttm) | -129189000 EUR |
| Diluted EPS (ttm) | -3.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 132.07M EUR |
| Total Cash Per Share (mrq) | 3.47 EUR |
| Total Debt (mrq) | 1.97M EUR |
| Total Debt/Equity (mrq) | 1.4 EUR |
| Current Ratio (mrq) | 3.528 |
| Book Value Per Share (mrq) | 3.713 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -114241000 EUR |
| Levered Free Cash Flow (ttm) | -66185376 EUR |
Profile of Mirum Pharmaceuticals, Inc.
| Country | Germany |
| State | CA |
| City | Foster City |
| Address | 950 Tower Lane |
| ZIP | 94404 |
| Phone | 650 667 4085 |
| Website | https://www.mirumpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 200 |
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of primary sclerosing cholangitis and primary biliary cholangitis in adults. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Q&A For Mirum Pharmaceuticals, Inc. Stock
What is a current 08D.F stock price?
Mirum Pharmaceuticals, Inc. 08D.F stock price today per share is 23 EUR.
How to purchase Mirum Pharmaceuticals, Inc. stock?
You can buy 08D.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mirum Pharmaceuticals, Inc.?
The stock symbol or ticker of Mirum Pharmaceuticals, Inc. is 08D.F.
Which industry does the Mirum Pharmaceuticals, Inc. company belong to?
The Mirum Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does Mirum Pharmaceuticals, Inc. have in circulation?
The max supply of Mirum Pharmaceuticals, Inc. shares is 49.85M.
What is Mirum Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Mirum Pharmaceuticals, Inc. PE Ratio is now.
What was Mirum Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Mirum Pharmaceuticals, Inc. EPS is -3.44 EUR over the trailing 12 months.
Which sector does the Mirum Pharmaceuticals, Inc. company belong to?
The Mirum Pharmaceuticals, Inc. sector is Healthcare.